PhD Žiga Jakopin
no.: 26496

researcher – active in research organisation

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy
3.01.00	Medical sciences	Microbiology and immunology

Bibliography Representative bibliographic units | Personal | COBISS+

Evaluation (metodology)

Points

1,053.97

A''

245.93

753.4

A1/2

867.44

CI10

1,517

CImax

133

h10

4.05

0.22

Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020)

Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	62	1,661	1,472	23.74
Scopus	64	1,800	1,599	24.98

Mentoring junior researchers

no.	Name and surname	Type	Period	Code
1	Veronika Weiss	Bologna doctoral studies	10/1/2020 - 9/30/2024	54787

Doctoral dissertations and other final papers Show

Employments

Type of employment	Research org.	Research group
Full time employment (120%, RD:70%)	University of Ljubljana, Faculty of Pharmacy	Chair for Pharmaceutical Chemistry

Research projects Legend

no.	Code	Title	Period	Head	No. of publications
1.	BI-RS/23-25-016	Confronting multidrug-resistant Acinetobacter baumanii infection by DNA gyrase and topoisomerase inhibitors	7/1/2023 - 12/31/2025	PhD Žiga Jakopin	214
2.	J3-4496	Next-generation adjuvants for mucosal vaccines	10/1/2022 - 9/30/2025	PhD Žiga Jakopin	1,414
3.	J1-3031	Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance	10/1/2021 - 9/30/2025	PhD Nace Zidar	1,158
4.	BI-US/22-24-182	Characterization of NOD2 receptor ligand binding	7/1/2022 - 6/30/2024	PhD Žiga Jakopin	214
5.	J3-2517	Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants	9/1/2020 - 12/31/2023	PhD Žiga Jakopin	2,442
6.	J1-2485	The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs	9/1/2020 - 8/31/2023	PhD Izidor Sosič	1,100
7.	J1-1717	Development of novel Hsp90 inhibitors with anticancer activity	7/1/2019 - 6/30/2023	PhD Tihomir Tomašić	2,064
8.	J3-9256	Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants	7/1/2018 - 6/30/2022	PhD Žiga Jakopin	3,048
9.	J1-8140	Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)	5/1/2017 - 4/30/2020	PhD Metka Filipič	4,032

ARIS research and infrastructure programmes Legend

no.	Code	Title	Period	Head	No. of publications
1.	P1-0420	Advanced immunological drugs and cell-based approaches in pharmacy	1/1/2022 - 12/31/2027	PhD Žiga Jakopin	1,410
2.	I0-E011	EATRIS	1/1/2024 - 12/31/2024	PhD Irena Mlinarič Raščan	2,082
3.	I0-E011	Sofinanciranje izvajanja mednarodnega infrastrukturnega projekta (Slovene)	1/1/2023 - 12/31/2023	PhD Irena Mlinarič Raščan	1,900
4.	I0-E011	Sofinanciranje izvajanja mednarodnega infrastrukturnega projekta EATRIS (Slovene)	1/1/2022 - 12/31/2022	PhD Irena Mlinarič Raščan	2,004
5.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	1/1/2015 - 12/31/2021	PhD Stanislav Gobec	6,517
6.	I0-0022	Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL) (Slovene)	1/1/2015 - 12/31/2021	PhD Anton Ramšak	14,457
7.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	1/1/2009 - 12/31/2014	PhD Danijel Kikelj	6,386
8.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	1/1/2004 - 12/31/2008	PhD Danijel Kikelj	6,446

International projects

no.	Code	Title	Period	Head	No. of publications
1.	COST-CA16231	European Network of Vaccine Adjuvants	11/13/2017 - 11/12/2021	PhD Žiga Jakopin
2.	COST-CA15138	European Network of Multidisciplinary Research and Translation of Autophagy knowledge (TRANSAUTOPHAGY)	4/22/2016 - 4/21/2020	PhD Žiga Jakopin

We were not given permission by the researcher to publish data.